Company Overview - Crown Reserve Acquisition Corp. I is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities [2] - The company may pursue acquisition opportunities across various industries but will focus on sectors where it has core competencies, including pharma, medical technology, medical equipment, and healthcare IT [2] Initial Public Offering (IPO) Details - The company closed its initial public offering of 17,250,000 units at a price of $10.00 per unit, resulting in gross proceeds of $172,500,000 [1] - The units began trading on the Nasdaq Global Market under the ticker symbol "CRACU" on November 7, 2025 [1] - Each unit consists of one Class A ordinary share, one-half of one redeemable warrant, and one right to receive one-fifth of one Class A ordinary share upon the consummation of an initial business combination [1] - An amount equal to $10.00 per unit was deposited into a trust account upon the closing of the offering [1] Management Team - The management team is led by Prashant Patel, Chief Executive Officer and Chairman, and Eric Sherb, Chief Financial Officer and Director [3] - The Board includes members Michael Peterson, Donald G. Fell, Avinash Wadhwani, and Mayur Doshi [3] Advisory and Management Support - Polaris Advisory Partners, a division of Kingswood Capital Partners LLC, acted as the sole book-running manager for the offering [4] - Thunder Rock Capital, LLC, a division of Finalis Securities LLC, served as an advisor to the company's management team [4] Regulatory Information - A registration statement relating to the securities was filed with the U.S. Securities and Exchange Commission (SEC) and became effective on September 26, 2025 [5]
Crown Reserve Acquisition Corp. I Announces the Closing of $172,500,000 Initial Public Offering